Sarah Palackdharry

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition”.

Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005632

N/A

1.8DataRank · unranked

69 citations

Benyamin Yaniv, Sarah Palackdharry, Maria Lehn, Mario Medvedovic, Timothy Stone +10 more

Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3351

N/A

0.780DataRank · unranked

180 citations

Shuchi Gulati, Sarah Palackdharry, Benjamin H. Hinrichs, Francis P. Worden, Matthew O. Old +21 more

PD1 blockade enhances K+ channel activity, Ca2+ signaling, and migratory ability in cytotoxic T lymphocytes of patients with head and neck cancer

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000844

N/A

0DataRank · unranked

33 citations

Vaibhavkumar S. Gawali, Ameet A. Chimote, Maria Lehn, Sarah Palackdharry, Benjamin H. Hinrichs +6 more

Determining the molecular landscape and impact on prognosis in HPV-associated head and neck cancer

Cancers of the Head & Neck(2020)10.1186/s41199-020-00058-2

N/A

0DataRank · unranked

11 citations

Sarah Palackdharry, Logan Roof, Christina A. Wicker, Jonathan R. Mark, Zheng Zhu +5 more

Durvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3886

N/A

0DataRank · unranked

29 citations

McKenzie Crist, Muhammed Kashif Riaz, Vinita Takiar, Maria Lehn, Ilaina Monroe +6 more

Data from Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma

(2023)10.1158/1078-0432.c.6532305

N/A

0DataRank · unranked

0 citations

Shuchi Gulati, Sarah Palackdharry, Benjamin H. Hinrichs, Francis P. Worden, Matthew Old +21 more

Data from Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma

(2023)10.1158/1078-0432.c.6532305.v1

N/A

0DataRank · unranked

0 citations

Shuchi Gulati, Sarah Palackdharry, Benjamin H. Hinrichs, Francis P. Worden, Matthew Old +21 more